Business Context and Reporting Period
CareCloud, Inc. (Nasdaq: MTBC) filed a Current Report on Form 8-K dated February 14, 2022. The filing reports the entry into a material definitive agreement to facilitate the sale of preferred stock.
Key Financial Metrics and Transaction Details
This filing does not report operational financial metrics such as revenue, profit, cash flow, or margins. The primary financial data relates to a new capital raising facility:
- Instrument: 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock (Symbol: MTBCO).
- Aggregate Offering Price: Up to $35 million.
- Agent: B. Riley Securities, Inc.
- Commission: 3.0% of the gross sale price per share sold.
- Method: At-the-market offering pursuant to Rule 415 under the Securities Act of 1933.
Material Changes
The material change reported is the execution of an At Market Issuance Sales Agreement on February 14, 2022. This agreement grants the Company the option, but not the obligation, to issue and sell shares of Series B Preferred Stock through B. Riley. The agreement may be terminated by either party upon five days' prior notice or automatically upon the sale of all shares subject to the agreement.
Guidance, Outlook, and Risks
The filing does not provide updated financial guidance or management commentary on future operational outlook. Key contingencies and terms include:
- Sales are subject to satisfaction of certain conditions set forth in the Sales Agreement.
- The Company may suspend offers under the agreement at any time.
- The issuance is made pursuant to an effective shelf registration statement on Form S-3 (File No. 333-255094).
- The filing explicitly states it does not constitute an offer to sell securities in jurisdictions where such an offer would be unlawful.
Investor Verification Checklist
- Verify the actual volume of Series B Preferred Stock sold under this agreement in subsequent filings.
- Review the attached At Market Issuance Sales Agreement (Exhibit 1.1) for specific conditions precedent to sales.
- Monitor the Company's cash position to determine if the $35 million facility is utilized.
- Check for the filing of the prospectus supplement referenced in the text.